Penthrox® Europe
Penthrox® Europe

This website is an information resource about Penthrox® intended for healthcare professionals only.

I am a healthcare professional

Patients who have been given Penthrox® can find the Patient Information Leaflet (PIL) here.

Report adverse events

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. By reporting side effects, you can help provide more information on the safety of medicine.

Mundipharma routinely monitors the safety of all its medicines, including reviewing safety data from clinical studies and collecting reports of adverse events. If you are a patient or are aware of a patient who has experienced an adverse event, overdose or unexpected benefits with one of our products, please also contact Mundipharma by calling +44 (0) 1223 424 211 or by emailing Mundipharma will only use your details to contact you about your adverse event report.

Penthrox® is a registered trademark of Medical Developments International Limited and is used under licence. The Mundipharma network of independent associated companies has exclusive rights in 40 European countries, but excluding the UK and Ireland.

Copyright © 2020 Mundipharma International Limited. All rights reserved.


Penthrox® Europe - Don't let trauma pain get in the way

Penthrox® – for emergency relief of moderate-to-severe pain in conscious adult patients with trauma and associated pain.1

Please always refer to your local Summary of Product Characteristics.

Get to know PenthroX®

The Mundipharma network of independent associated companies has exclusive rights to this innovative, patient-controlled, inhaled pain relief in 40 European countries (excluding the UK and Ireland).

Please continue to explore this website for detailed information about Penthrox® and useful materials.